Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.

Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.

BACKGROUND:Proton pump inhibitors (PPIs) are one of the most widely prescribed medications across the world. PPIs have been associated with significant electrolyte abnormalities including hypomagnesaemia. We explored the prevalence of PPI associated hypomagnesaemia (PPIH) in different Chronic Kidney...

Full description

Bibliographic Details
Main Authors: John Hughes, Diana Y Y Chiu, Phillip A Kalra, Darren Green
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5969743?pdf=render

Internet

http://europepmc.org/articles/PMC5969743?pdf=render

Similar Items